Ye Li

发表

LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications

Zhiwen Zhang, Min-Jie Jin, Jingjing Zhao, 2022, Journal of Cancer.

mRNA expression and DNA methylation analysis of the inhibitory mechanism of H2O2 on the proliferation of A549 cells

Shiqing Huang, Ye Li, Zhongheng Wei, 2020, Oncology letters.

DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway

Shifu Hou, Jingjing Zhao, Shiqing Huang, 2021, Oncology letters.

Small peptide LINC00511-133aa encoded by LINC00511 regulates breast cancer cell invasion and stemness through the Wnt/β-catenin pathway.

Yantao Wei, Shiqing Huang, Ye Li, 2023, Molecular and cellular probes.

Ferroptosis inhibitor regulates the disease progression of systematic lupus erythematosus mice model through Th1/Th2 ratio.

Shifu Hou, Shiqing Huang, Ye Li, 2022, Current molecular medicine.

3-hydroxy butyrate dehydrogenase 2 deficiency aggravates systemic lupus erythematosus progression in a mouse model by promoting CD40 ligand demethylation

Shifu Hou, Jingjing Zhao, Ye Li, 2022, Bioengineered.

A putative competing endogenous RNA network in cisplatin-resistant lung adenocarcinoma cells identifying potentially rewarding research targets

Shiqing Huang, Ye Li, Zhongheng Wei, 2020, Oncology letters.

The emerging roles of LINC00511 in breast cancer development and therapy

Ye Li, S. Sooranna, Lifeng Zhao, 2024, Frontiers in oncology.

Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocol

Ye Li, Junyu Guo, Mingwei Wei, 2023, BMJ Open.